SCHEMBL457573

SCHEMBL457573

CCCCCCCC(CCCO)OC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HSD17B10 Q99714 1/20 0.48
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.44
PTPN1 P18031 1/20 0.44
SPHK1 Q9NYA1 2/20 0.41
CYP2D6 P10635 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19464195 1.00 LMNA (0.48) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7875788 0.91 LMNA (0.52) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL1705822 0.91 LMNA (0.52) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL1705524 0.91 LMNA (0.52) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7869209 0.91 LMNA (0.52) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7863756 0.91 LMNA (0.52) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL18342526 0.89 LMNA (0.50) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL18342558 0.89 LMNA (0.50) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7870895 0.87 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL10893740 0.87 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614055-A2 PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE FOSAMPRENAVIR CALCIUM AND ITS INTERMEDIATES Lupin Limited (IN) 2013-07-17 EP disclosed
WO-2012032389-A2 PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE FOSAMPRENAVIR CALCIUM AND ITS INTERMEDIATES LUPIN LIMITED (IN) 2012-03-15 WO disclosed